Cargando…
IFNλ: balancing the light and dark side in pulmonary infection
Interferon (IFN) represents a well-known component of antiviral immunity that has been studied extensively for its mechanisms of action and therapeutic potential when antiviral treatment options are limited. Specifically in the respiratory tract, IFNs are induced directly on viral recognition to lim...
Autores principales: | Antos, Danielle, Alcorn, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470512/ https://www.ncbi.nlm.nih.gov/pubmed/37278532 http://dx.doi.org/10.1128/mbio.02850-22 |
Ejemplares similares
-
Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer
por: Wang, Zhen Zhen, et al.
Publicado: (2023) -
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
por: Davidson, Sophia, et al.
Publicado: (2016) -
Is the Epididymis a Series of Organs Placed Side By Side?
por: Domeniconi, Raquel F., et al.
Publicado: (2016) -
Understanding IFNλ in rheumatoid arthritis
por: de Groen, Rik A, et al.
Publicado: (2014) -
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
por: Duong, Francois H.T., et al.
Publicado: (2014)